Multidetector Computed Tomography Coronary Angiography for the Assessment of Coronary In-Stent Restenosis




The investigators conducted a review to evaluate the diagnostic performance of multidetector computed tomography (MDCT) for coronary stent evaluation. The prespecified inclusion criteria selected prospective or retrospective human studies published in English. Studies that did not report raw numbers of diagnostic accuracy for the detection of in-stent restenosis were excluded. The data from 24 studies are reported, 6 performed with old-generation scanners (4-, 16-, and 40-slice MDCT) and 18 performed with 64-slice MDCT or dual-source MDCT. With old-generation MDCT, up to 18% of coronary stents were missed, the rate of nonevaluable stents ranged from 2.6% to 23.5%, and the overall feasibility and diagnostic accuracy were 90.4% and 90%, respectively. With 64-slice MDCT, no stent was missed, and the overall feasibility and diagnostic accuracy were 90.4% and 91.9%, respectively. Advancements in MDCT and stent technologies may further reduce the number of nonassessable stents and improve diagnostic performance.


Invasive coronary angiography (ICA) is the most dependable imaging modality for detecting in-stent restenosis (ISR). With the introduction of multidetector computed tomography (MDCT), coronary computed tomographic angiography has emerged as a new tool for diagnosing coronary artery disease and conducting patient follow-up. Coronary computed tomographic angiography with 16- and 40-slice scanners has >90% sensitivity and specificity for the detection of significant coronary stenosis (luminal diameter >50%). Studies performed using 64-slice MDCT or dual-source MDCT (DSCT) have shown an improvement in diagnostic performance for the detection of significant coronary stenosis on per segment and a per patient analyses due to greater spatial and temporal resolution. However, blooming artifacts caused by metallic stent struts may still impair the visualization of stent lumen and the quantification of luminal narrowing. Our aim was to perform a structured review of all studies that assessed the diagnostic performance of MDCT for the detection of coronary ISR.


Methods


Our prespecified inclusion criteria selected prospective or retrospective human studies published in English. Studies that did not report raw numbers of diagnostic accuracy (true-positive, true-negative, false-positive, and false-negative rates) for the detection of ISR were excluded. Using our predetermined criteria, we searched Medline combining the search terms “computed tomography,” “coronary stent,” “restenosis,” and “angiography” and included reports published through May 2009. The studies were performed mainly in patients referred for ICA because of suspected ISR (angina, positive results on electrocardiographic [ECG] stress testing or myocardial perfusion imaging), with the exception of 4 studies performed in asymptomatic patients. The overall feasibility of stent evaluation on MDCT (the ratio of evaluable segments to the total number of segments) was measured. We assessed the overall sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of MDCT for the detection of ISR >50% from a segment-based analysis against the standard of findings on ICA.




Results


Technology and data acquisition


High spatial and temporal resolution is needed to evaluate coronary arteries, particularly in case of stented vessels. Therefore, ICA is the gold standard technique for ruling out ISR. In the late 1990s, MDCT with retrospective ECG gating was introduced. This technology, characterized by thinner and multiple sections and lower pitch factors (table feed/gantry rotation) consists of a continuous spiral scan of the heart with simultaneous ECG recording. This translates into higher spatial and temporal resolution that allows the evaluation of stented segments.


The main technical factors that influence diagnostic performance are the number of slices, slice thickness, gantry rotation time, scanning parameters, heart rate during the scan, the type of contrast injection protocol, and postprocessing analysis ( Tables 1 and 2 ). A progressive increase in the number of slices from 4 up to 40 allowed a contemporaneous increase in spatial resolution from 1.25 to 0.5 mm, providing promising results in ISR detection.



Table 1

Technical background, data acquisition, and effective doses of 4-, 16-, and 40-slice computed tomography for the detection of in-stent restenosis




















































































































Study Journal Manufacturer Source No. of Slices/Slice Thickness (mm) Gantry Rotation Time (ms) Tube Current (mA) Tube Voltage (kVp) β Blockade/Nitrates ECG Gating Modulation Dose Contrast Agent Protocol Sharp Kernel Type of Analysis Effective Radiation Dose (mSv)
Cademartiri et al (2005) AJC Siemens Single 16/0.75 370 600 120 OR/no Retrospective Yes Bolus tracking No Qualitative 11.8–16.3
Gaspar et al (2005) JACC Philips Single 40/0.6 420 600–800 120 OR/no Retrospective Yes Bolus tracking Yes Qualitative 9.9 ± 2.8
Mazzarotto et al (2006) JCM Philips Single 4/1.25 500 350 120 IV/yes Retrospective No Test bolus Yes Qualitative NR
Soon et al (2007) IMJ GE Single 16/0.6–1.25 500 385–440 120 OR/no Retrospective Yes Bolus tracking No Qualitative 15–23
Kefer et al (2007) ER Philips Single 16/0.75 420 400 140 OR/no Retrospective Yes Bolus tracking Yes Qualitative 8
Tedeschi et al (2008) JCM Toshiba Single 16/0.5 400 350 120 OR/no Retrospective Yes Bolus tracking Yes Semiquantitative NR

AJC = American Journal of Cardiology ; ER = European Radiology ; IMJ = Internal Medicine Journal ; IV = intravenous administration; JACC = Journal of the American College of Cardiology ; JCM = Journal of Cardiovascular Medicine ; NR = not reported; OR = oral administration.


Table 2

Technical background, data acquisition, and effective doses of 64-slice computed tomography for the detection of in-stent restenosis



































































































































































































































































































































Study Journal Manufacturer Source No. of Slices/Slice Thickness (mm) Gantry Rotation Time (ms) Tube Current (mA) Tube Voltage (kVp) β Blockade/Nitrates ECG Gating Modulation Dose Contrast Agent Protocol Sharp Kernel Type of Analysis Effective Radiation Dose (mSv)
Rixe et al (2006) EHJ Siemens Single 32 × 2/0.6 330 850 120 OR, IV/yes Retrospective Yes (34 patients) Test bolus No Qualitative NR
Van Mieghem et al (2006) Circ Siemens Single 32 × 2/0.6 (43 patients) 330 900 120 OR/no Retrospective No Bolus tracking Yes Semiquantitative/quantitative 15.2–21.4
Rist et al (2006) AR Siemens Single 32 × 2/0.6 330 850 120 IV/no Retrospective Yes Bolus tracking Yes Semiquantitative 8–10
Oncel et al (2007) Rad Siemens Single 32 × 2/0.6 330 900 120 IV/yes Retrospective No Bolus tracking Yes Qualitative NR
Ehara et al (2007) JACC Siemens Single 32 × 2/0.6 330 800 120 OR/yes Retrospective No Bolus tracking Yes Semiquantitative 12.1
Cademartiri et al (2007) JACC Siemens Single 32 × 2/0.6 330 900 120 OR/no Retrospective No Bolus tracking Yes Quantitative 15–20
Toshiba Single 64/0.5 400 712 120 Retrospective No Yes
Carabba et al (2007) AJC Philips Single 64/0.6 400 600–850 120 No/no Retrospective No Bolus tracking No Quantitative 12.8 ± 2.3
Das et al (2007) Rad Siemens Single 64/0.6 370 750–850 120 OR, IV/no Retrospective No Bolus tracking Yes Semiquantitative NR
Schuijf et al (2007) Rad Toshiba Single 64/0.5 400–500 350 120 No/no Retrospective Yes Bolus tracking Yes Semiquantitative 10–15
Pugliese et al (2008) Heart Siemens Dual 32 × 2/0.6 330 412 120 No/no Retrospective Yes Bolus tracking Yes Quantitative 12.1–16.7
Oncel et al (2008) AJR Siemens Dual 32 × 2/0.6 330 390 120 No/yes Prospective No Bolus tracking Yes Semiquantitative 12.3
Carbone et al (2008) ER Siemens Single 32 × 2/0.6 330 800 120 OR/no Retrospective No Bolus tracking Yes Semiquantitative 15.0
Manghat et al (2008) AJC GE Single 64/0.6 350 900 120 OR/no Retrospective No Bolus tracking Yes Semiquantitative NR
Hecht et al (2008) AJC Philips Single 64/0.6 600–1,000 120–140 OR, IV/no Retrospective No Bolus tracking Yes Qualitative/quantitative 13–18
Nakamura et al (2008) IJC GE Single 64/0.6 350 300–750 120 OR/no Retrospective Yes Bolus tracking Yes Qualitative NR
Andreini et al (2009) AJC GE Single 64/0.6 350 650 120 IV/no Retrospective Yes Bolus tracking Yes Semiquantitative/quantitative NR
Pontone et al (2009) JACC GE Single 64/0.6 350 700 120 IV/no Retrospective Yes Bolus tracking Yes Quantitative 5.7
Prospective Yes Yes 20.5
Pflederer et al (2009) AJC Siemens Dual 64 × 2/0.6 330 400 120 OR, IV/yes Retrospective Yes Test bolus Yes Semiquantitative 14.8 ± 4.8

AJR = American Journal of Roentgenology ; AR = Academic Radiology ; Circ = Circulation ; EHJ = European Heart Journal ; IJC = International Journal of Cardiology ; Rad = Radiology . Other abbreviations as in Table 1 .


The temporal resolution of old-generation scanners was further improved in the mid-2000s with the introduction of 64-slice multidetector computed tomographic scanners and DSCT. Moreover, in addition to detector improvements, these scanners were equipped with much faster gantries, resulting in effective temporal resolution up to 83 ms.


However, matrices with such thin layers required very high tube current and voltage, translating to radiation exposure increases. The studies using 64-slices scanners included in this review reported effective x-ray doses ranging from 10 and 20.5 mSv. Several strategies have been proposed to reduce radiation dose, such as modulation dose protocols, dual-source scanning, and prospective ECG gating. With the latter technique, the table remains stationary while the x-ray tube rotates around the patient and is advanced for the subsequent scan only when data acquisition is completed. This allows a reduction of up to 5.7 mSv without impairing diagnostic accuracy for ISR detection.


Several studies demonstrated that heart rate has an important impact on the diagnostic performance of MDCT. Although the heart rate limit depends on the temporal resolution of the scanner used, a target heart rate ≤65 beats/min is always desirable. This was achieved with β blockers administered orally 60 to 90 minutes before the scan, intravenously immediately before, or both. Image quality has also been shown to improve with nitroglycerin, and therefore, some investigators administered sublingual nitrates immediately before scans to achieve maximum coronary vasodilatation.


With regard to the contrast injection protocol, no difference was found between the “bolus-tracking technique,” faster and more reliable, and the “test bolus technique.” With regard to postprocessing analysis, image data sets were analyzed in all studies using reconstruction protocols and vessel analysis ( Figure 1 ). To improve stent visibility and to decrease artifacts, dedicated kernels can be used. Reconstruction kernels are mathematical calculations applied to raw data that control low contrast detectability and spatial resolution in the reconstructed images. Although a smooth kernel is suitable for the evaluation of the vessel lumen, vessel wall, and surrounding tissue, the visualization of high-density structures such as stents requires a sharp kernel ( Figure 2 ). Indeed, this was used for ISR evaluation in almost all studies reported in this review.




Figure 1


(A) MDCT (volume rendering) showing stents (arrows) implanted in the first diagonal branch (D1) and left circumflex coronary artery (LCX). (B) Multiplanar reconstruction of the left main coronary artery (LM) and LCX showing stent patency, confirmed by short-axis view of the proximal (C) and distal (D) stent segments. LAD = left anterior descending coronary artery.



Figure 2


(A) MDCT (volume rendering) showing multiple stents (arrows) implanted in the proximal segment and first marginal branch of the left circumflex coronary artery (LCX). (B) The blooming effect caused by the metallic struts hinders adequate stent luminal visualization with multiplanar reconstruction. (C) Use of a dedicated sharp kernel reduces the blooming effect, with a significant improvement in stent luminal visualization.


Finally, 3 different methods were used to determinate the degree of ISR: qualitative, semiquantitative, and quantitative. With the qualitative technique, significant ISR (diameter reduction ≥50%) was visually detected. With the semiquantitative method, a 4-point scale ranging from 1 (patent stent lumen) to 4 (stent occlusion) was used. In the quantitative measurement, the percentage of stenosis was calculated as the ratio between the diameters, measured in the short axis, of the narrower stent lumen and of the proximal and distal reference segments. However, no significant difference was reported in the accuracy of the qualitative and quantitative method.


Diagnostic performance of 4-, 16-, and 40-slice MDCT


Two of 6 studies included in the present review showed that multidetector computed tomographic scanners of this generation were unable to correctly identify all stent segments. Indeed, up to 18% of stents were not recognized in these studies, as well as in other studies not included in this review because of the exclusion criteria. The reasons were mainly motion artifacts and severe calcifications. Therefore, analysis was performed on the correctly identified stents only.


Table 3 lists the percentage of nonevaluable coronary stented segments and the diagnostic accuracy parameters reported in the 6 published studies that investigated the diagnostic performance of 4-, 16-, and 40-slice MDCT. The rate of coronary stents classified as not evaluable because of poor image quality ranged from 2.6% and 23.5%. The overall feasibility of MDCT was 90.4%. Image quality was impaired mainly by motion artifacts related to patients’ inability to hold their breath or refrain from chest movement. These were the reasons for uninterpretable stented segments in 100% of the cases in a study by Cademartiri et al and in 40% of the cases in a study by Gaspar et al and represented the first cause of nonevaluability in a study by Kefer et al. This is due to the lower temporal resolution of scanners of this generation, causing longer scan times requiring that patients hold their breath longer.



Table 3

Diagnostic performance of 4-, 16-, and 40-slice computed tomographic scanners for the detection of in-stent restenosis (using stents correctly identified by multidetector computed tomography)




















































































Study Journal No. of Patients/No. of Stents Not Evaluable (%) Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%)
Cademartiri et al (2005) AJC 51/76 2.6 (2/76) 83 (5/6) 98 (67/68) 83 (5/6) 98 (67/68) 97 (72/74)
Gaspar et al (2005) JACC 65/111 4.5 (5/111) 53 (9/17) 88 (78/89) 45 (9/20) 91 (78/86) 82 (87/106)
Mazzarotto et al (2006) JCM 24/34 23.5 (8/34) 91 (21/23) 67 (2/3) 95 (21/22) 50 (2/4) 88 (23/26)
Soon et al (2007) IMJ 37/47 4.2 (2/47) 71 (5/7) 97 (37/38) 83 (5/6) 95 (37/39) 93 (42/45)
Kefer et al (2007) ER 50/69 7.2 (5/69) 67 (12/18) 98 (50/51) 92 (12/13) 89 (50/56) 90 (62/69)
Tedeschi et al (2008) JCM 72/90 21 (19/90) 82 (14/17) 96 (52/54) 87 (14/16) 94 (52/55) 93 (66/71)
Total 299/427 9.6 (41/427) 75 (66/88) 94 (286/303) 80 (66/83) 93 (286/308) 90 (352/391)

NPV = negative predictive value; PPV = positive predictive value. Other abbreviations as in Table 1 .


Another cause of impaired quality was the high-density artifacts generated by metallic stent struts. Three studies found that stent diameter may influence the evaluation of stent lumen on MDCT. In a study by Tedeschi et al, only 1 of 9 stents (11%) with diameters <3 mm was judged evaluable, compared with 60 of 81 stents (74%) with diameters ≥3 mm. In a study by Soon et al, all nonevaluable stents had diameters <3 mm. Similarly, in the study by Kefer et al, nonevaluable stents were of significantly smaller diameters. In the latter study, nonassessable stents had thinner struts (87 vs 110 μm). As listed in Table 3 , the overall diagnostic accuracy of the 6 studies included in this review was 90%. As shown in the study by Kefer et al, stent diameter plays a significant role in the correct evaluation of stent patency.


In conclusion, most of the studies using 4-, 16-, and 40-slice MDCT reported high overall feasibility for the evaluation of stent patency. However, some studies not included in this review because of the exclusion criteria showed more relevant rates of nonevaluable stents: 46% (106 of 232) in a study by Gilard et al and 77% (50 of 65) in a study by Schuijf et al.


Feasibility and imaging quality of 64-slice MDCT and DSCT


Table 4 lists the percentages of nonevaluable coronary stented segments reported in the 18 published studies that investigated the diagnostic performance of 64-slice MDCT and DSCT. With the exception of a very high rate (42%) of nonevaluable stents reported in a study published in 2006 by Rixe et al, the rate of coronary stents classified in the other studies as not evaluable because of poor image quality ranged from 0% to 19.5%. The overall feasibility of MDCT was 90.4%.



Table 4

Diagnostic performance of 64-slice computed tomography and dual-source computed tomography for the detection of in-stent restenosis




















































































































































































































Study Journal No. of Patients/No. of Stents Not Evaluable (%) Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%)
Rixe et al (2006) EHJ 64/102 42 (43/102) 86 (6/7) 98 (51/52) 86 (6/7) 98 (51/52) 97 (57/59)
Van Mieghem et al (2006) Circ 70/162 100 (10/10) 91 (55/60) 67 (10/15) 100 (55/55) 93 (65/70)
Rist et al (2007) AR 25/46 2 (1/46) 75 (6/8) 92 (34/37) 67 (6/9) 94 (34/36) 89 (40/45)
Oncel et al (2007) Rad 30/39 0 (0/39) 89 (17/19) 95 (19/20) 94 (17/18) 90 (19/21) 92 (36/39)
Ehara et al (2007) JACC 81/125 12 (15/125) 91 (20/22) 93 (82/88) 77 (20/26) 98 (82/84) 93 (102/110)
Cademartiri et al (2007) JACC 182/192 7 (14/192) 95 (19/20) 93 (147/158) 63 (19/30) 99 (147/148) 93 (166/178)
Carrabba et al (2007) AJC 41/87 0 (0/87) 84 (11/13) 97 (73/74) 92 (11/12) 97 (73/75) 96 (84/87)
Das et al (2007) Rad 53/110 2.7 (3/110) 97 (31/32) 88 (66/75) 77 (31/40) 98 (66/67) 91 (96/107)
Schuijf et al (2007) Rad 50/76 14 (11/76) 100 (6/6) 100 (52/52) 100 (6/6) 100 (52/52) 100 (58/58)
Pugliese et al (2008) Heart 100/178 5 (9/178) 94 (37/39) 92 (128/130) 77 (37/48) 98 (128/130) 98 (165/169)
Oncel et al (2008) AJR 35/48 15 (7/48) 100 (17/17) 94 (29/31) 89 (17/19) 100 (29/29) 96 (46/48)
Carbone et al (2008) ER 41/74 19.5 (21/74) 75 (12/16) 86 (32/37) 71 (11/14) 89 (32/36) 83 (44/53)
Manghat et al (2008) AJC 40/114 9.6 (11/114) 85 (17/20) 86 (68/79) 61 (17/28) 96 (68/71) 83 (85/103)
Hecht et al (2008) AJC 67/132 0 (0/132) 94 (16/17) 74 (85/115) 39 (16/46) 99 (85/86) 77 (101/132)
Nakamura et al (2008) IJC 49/75 14.6 (11/75) 67 (2/3) 92 (56/61) 29 (2/7) 98 (56/57) 91 (58/64)
Andreini et al (2009) AJC 100/179 5 (9/179) 87 (34/39) 98 (128/131) 92 (35/38) 96 (128/133) 95 (162/170)
Pontone et al (2009) JACC 80/48 8 (4/48) 92 (11/12) 94 (30/32) 85 (11/13) 97 (30/31) 93 (41/44)
80/66 6 (4/66) 73 (8/11) 96 (49/51) 80 (8/10) 94 (49/52) 92 (57/62)
Pflederer et al (2009) AJC 112/150 10 (15/150) 84 (16/19) 95 (110/116) 73 (16/22) 97 (110/113) 93 (126/135)
Total 1,300/2,003 9.6 (178/1,841) 89.7 (296/330) 92.2 (1,294/1,399) 72.5 (296/408) 97.4 (1,294/1,328) 91.9 (1,590/1,729)

Abbreviations as in Tables 1 to 3 .

Prospective ECG gating.


Retrospective ECG gating.



The main reasons for impaired image quality and stent assessment were high-density artifacts generated by metallic stent struts, followed by motion artifacts related to patients’ inability to hold their breath or refrain from chest movement, misalignment of slices due to heart rate variation or premature beats, and blooming effects due to vessel calcifications.


Some investigators evaluated stent and patient characteristics that may have a negative impact on image quality with MDCT. A number of stent characteristics, such as diameter, type, strut thickness, material, cell shape, and the complexity of the interventional procedure (bifurcation or overlapping stenting) were evaluated. Almost all studies showed that stent diameter plays a major role in the evaluation of the stent lumen. In a study performed at our institution, we found a significant increase in evaluability in stents with diameters ≥3 mm compared to those with diameters <3 mm. Accordingly, the mean diameter of evaluable stents was significantly larger than that of nonevaluable stents. Rixe et al confirmed these findings, showing that the mean diameter of evaluable stents was significantly larger than the diameter of nonevaluable stents (3.28 vs 3.03 mm). Two studies performed by Oncel et al, the first with 64-slice MDCT and the second with DSCT, and a study by Carbone et al showed a significant difference in the percentage of evaluable stented segments between ≥3-mm-diameter stents and <3-mm-diameter stents. In a study by Pflederer et al, the mean diameter of stents classified as assessable (3.30 mm) was significantly higher than that of stents classified as nonassessable (3.0 mm); in the same study, multivariate analysis showed that diameter was significantly associated with stent assessability. Finally, Pugliese et al, using DSCT, demonstrated that all stents classified as not evaluable had diameters ≤2.75 mm, confirming the key role of stent size.


Two studies evaluated the effect of strut thickness on stent evaluability, demonstrating a significant reduction in artifacts with thinner stents (<100 μm). The influence of stent material on image quality was assessed by Oncel et al, who found that the cobalt-chromium alloy produced fewer metal artifacts than did other materials.


The finding that stent luminal visibility greatly varies depending on the stent type was also reported in an in vitro study by Maintz et al. Using a 64-slice MDCT, they showed that all types of stents made of cobalt-chromium alloy had luminal visibility >66%. In another in vitro study performed with DSCT and using all 4 different type of kernel reconstruction protocols, Maintz et al confirmed the influence of stent material on image quality, showing that the mean luminal diameter was highest with stents made using magnesium (WE43) and lowest with those made using tantalum. A study by Schuijf et al showed that image quality was significantly lower in overlapping stents than in stents without overlap. Finally, no significant difference was found between stents with open or closed cell designs in the 2 studies that evaluated this feature.


Two studies performed with 64-slice MDCT showed higher feasibility when the heart rate during the scan was <60 versus ≥60 beats/min. In our study, heart rate was also a predictor of better feasibility on multivariate analysis. Also, the study by Schuijf et al confirmed this finding, showing that the mean heart rate in the interpretable stents was significantly lower than that in the noninterpretable stents (55 vs 72 beats/min). In contrast, the 2 studies performed with DSCT showed no significant difference between <70 and ≥70 beats/min during the scan. This was likely due to the increased temporal resolution of this type of scanner in comparison to single-source scanners.


In conclusion, concerning stent characteristics that may influence stent image quality, the role of stent diameter is critical, as shown by almost all studies included in this review. The role of strut thickness is still controversial, with studies in which this parameter affected stent assessment and other studies that found no impact. However, it is important to note that in the latter studies, the cutoff for distinguishing thin from thick strut stents was higher (110 vs 120 or <140 vs >140 μm). The role of stent material has been demonstrated by in vitro studies and confirmed by the study of Oncel et al. Finally, high-density artifacts generated by metallic stent struts are more evident in overlapping stents. Concerning patient characteristics, heart rate during the scan has a fundamental role on stent image quality, as in the case of native coronary arteries. Figure 3 shows 2 cases of nonevaluable stents due to high-density artifacts generated by metallic stent struts and to the misalignment of slices related to heart rate variability.




Figure 3


(A,B) Multidetector computed tomographic multiplanar reconstructions of the left anterior descending coronary artery showing high-density artifacts generated by metallic stent struts (arrows) that prevent the correct evaluation of the proximal stent lumen. (C,D) Multidetector computed tomographic multiplanar reconstructions of 2 overlapping stents implanted in the proximal right coronary artery showing artifacts due to slice misalignment caused by heart rate variations during the scan.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Dec 23, 2016 | Posted by in CARDIOLOGY | Comments Off on Multidetector Computed Tomography Coronary Angiography for the Assessment of Coronary In-Stent Restenosis

Full access? Get Clinical Tree

Get Clinical Tree app for offline access